In a notice published in the Federal Register for 05/04/2011, the FDA Science Board, an advisory panel that provides advice to the FDA Commissioner and the Commission on "specific complex and technical issues as well as, emerging issues within the scientific community, in industry and academia . . . .advice to the Agency on keeping pace with … Continue Reading